2024-513729-22-01RecruitingPhase 1
Phase I study of 225Ac-PSMA I&T in prostate cancer
Source: EU CTIS (euclinicaltrials.eu) · Last updated 30 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 5 Sept 2024
- Start date
- 1 Feb 2022
- Lead sponsor
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
- Diseases
- Prostate cancer
- EU CT number
- 2024-513729-22-01
- EudraCT number
- 2020-001089-13
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 30
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) | Rotterdam | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.